Animal Antibiotics and Antimicrobials Market worth $4.73 Billion by 2021

The report “Animal Antibiotics and Antimicrobials Market by Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Fluoroquinolone) Mode of Delivery (Premixes, Oral Powder, Injection) Animal (Food-producing & Companion) – Global Forecast to 2021″, published by MarketsandMarkets, the market witnessed significant growth during the last decade and is expected to grow at a CAGR of 4.6% between 2016 and 2021 to reach 4.73 Billion by 2021.

Further more information in details about Animal Antibiotics and Antimicrobials Market Best Chance to increase growth in revenue of your company. 

The market players, namely, Zoetis, Inc. (U.S.), Merck & Co., Inc. (U.S.), Bayer AG (Germany), Eli Lilly and Company (U.S.), and Virbac (France) held the major share of the Animal Antibiotics and Antimicrobials Market and will continue to dominate the market between 2016 and 2021. Some of the major players competing in this market are Zoetis, Inc. (U.S.), Bayer AG (Germany), Merck & Co., Inc. (U.S.), Eli Lilly and Company (U.S.), Virbac (France), Boehringer Ingelheim GmbH (Germany), Ceva Sante Animale (France), Vetoquinol S.A. (France), Sanofi (France), and Dechra Pharmaceuticals PLC (U.K.).

Let me know your suggestion regarding my post about Animal Antibiotics and Antimicrobials Market .